| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011668 |
| Receipt No. | R000013121 |
| Official scientific title of the study | Effects of green tea consumption on cognitive dysfunction and atherosclerosis: A randomized-controlled study |
| Date of disclosure of the study information | 2013/09/09 |
| Last modified on | 2017/09/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effects of green tea consumption on cognitive dysfunction and atherosclerosis: A randomized-controlled study | |
| Title of the study (Brief title) | Effects of green tea consumption on cognitive dysfunction and atherosclerosis | |
| Region |
|
|
| Condition | |||
| Condition | Dementia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the effects of green tea consumption on cognitive dysfunction |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the effects of green tea consumption on the arteriosclerosis markers. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Changes in Mini-Mental State Examination (MMSE) scores |
| Key secondary outcomes | Changes in sub-scores of MMSE
Changes in BMI, blood pressure, serum lipids, plasma glucose, HbA1c |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | green tea powder | |
| Interventions/Control_2 | placebo powder | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Obtained written informed consent from both the participant and care-giver before participation
2.Possible to consume green tea and placebo powder 3.Cognitive dysfunction based on MMSE; score < 28 4.Not taking any supplement possessing anti-oxidizing effects |
|||
| Key exclusion criteria | 1. Allergy to green tea
2. Severe cardiac, respiratory, renal, or hepatic dysfunction 3. Severe anemia 4. Diagnosed as inadequate to participate to the study by a doctor |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Yamada |
| Organization | University of Shizuoka |
| Division name | School of Pharmaceutical Sciences |
| Address | 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan |
| TEL | +81-54-264-5762 |
| hyamada@u-shizuoka-ken.ac.jp | |
| Public contact | |
| Name of contact person | Hiroshi Yamada |
| Organization | University of Shizuoka |
| Division name | School of Pharmaceutical Sciences |
| Address | 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan |
| TEL | +81-54-264-5762 |
| Homepage URL | http://u-shizuoka-ken.ac.jp |
| hyamada@u-shizuoka-ken.ac.jp | |
| Sponsor | |
| Institute | University of Shizuoka |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Central Research Institute, ITO EN, Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | White Cross Nursing Home |
| Name of secondary funder(s) | Japanese Ministry of Health, Labor, and Welfare |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 静岡県立大学(静岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | https://upload.umin.ac.jp/ |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013121 |